AbbVie Inc (ABBV)
Gross profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 39,430,000 | 33,903,000 | 40,640,000 | 38,751,000 | 30,417,000 |
| Revenue | US$ in thousands | 56,334,000 | 54,318,000 | 58,054,000 | 56,197,000 | 45,804,000 |
| Gross profit margin | 69.99% | 62.42% | 70.00% | 68.96% | 66.41% |
December 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $39,430,000K ÷ $56,334,000K
= 69.99%
The gross profit margin of AbbVie Inc has displayed fluctuating trends over the past five years. It increased from 66.41% as of December 31, 2020, to 68.96% as of December 31, 2021, indicating an improvement in the company's ability to generate profit from its core operations. The trend continued with a further rise to 70.00% by December 31, 2022, reflecting increased efficiency in managing production costs.
However, there was a notable decline in the gross profit margin to 62.42% by December 31, 2023, which may suggest challenges in controlling direct costs related to production. Nonetheless, the margin bounced back to 69.99% by December 31, 2024, nearing the peak achieved in 2022.
Overall, AbbVie Inc's gross profit margin has shown both positive and negative fluctuations over the five-year period, indicating varying levels of profitability and efficiency in managing production costs.
Peer comparison
Dec 31, 2024